Browsing by Author Chung, HC

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 中
Showing results 1 to 7 of 7
TitleAuthor(s)Issue Date
 
Analysis of the pan-Asian subgroup of patients in the NALA Trial: a randomized phase III NALA Trial comparing neratinib+capecitabine (N+C) vs lapatinib+capecitabine (L+C) in patients with HER2+metastatic breast cancer (mBC) previously treated with two or more HER2-directed regimens
Journal:Breast Cancer Research and Treatment
Dai, MSFeng, YHChen, SWMasuda, NYau, TChen, STLu, YSYap, YSAng, PCSChu, SCKwong, ALee, KSOw, SKim, SBLin, JChung, HCNgan, RKok, VCRau, KMSangai, TNg, TYTseng, LMBryce, RBebchuk, JChen, MCHou, MF
2021
 
Characterization of cues from natural multi-species biofilms that induce larval attachment of the polychaete Hydroides elegans
Journal:Aquatic Biology
Hung, OSLee, OOThiyagarajan, VHe, HPXu, YChung, HCQiu, JWQian, PY
2008
 
Interim report for a phase II, multi-centre, dose-escalating study of LB80380/ANA380 in hepatitis B patients with lamivudine-resistant YMDD mutant HBV
Proceeding/Conference:Journal of Hepatology
Lai, CLHan, KHYoon, SKUM, SHYuen, MFKim, HSKim, HRChung, HCKim, CRHsyu, PAverett, DKim, J
2005
 
Pembrolizumab versus paclitaxel for previously treated, advanced gastric or gastro-oesophageal junction cancer (KEYNOTE-061): a randomised, open-label, controlled, phase 3 trial
Journal:The Lancet
Shitara, KOzguroglu, MBang, Y-JBartolmeo, MDMandala, MRyu, M-HFornaro, LOlesinski, TCaglevic, CChung, HCMuro, KGoekkurt, EMansoor, WMcDermott, RSShacham-Shumueli, EChen, XMayo, CKang, SPOhtsu, AFuchs, CSKEYNOTE-061 investigatorsLam, KO
2018
 
Phase II multi-centre, dose-escalating study of LB80380 (ANA380) in hepatitis B patients with lamivudine-resistant YMDD mutant HBV
Proceeding/Conference:Journal of Hepatology
Lai, CLHan, KHYoon, SKUm, SHYuen, MFKim, HSKim, HRChung, HCKim, CRHsyu, PAverett, DWorland, SKim, J
2006
 
Ramucirumab as second-line treatment in patients with advanced hepatocellular carcinoma following first-line therapy with sorafenib: Patient-focused outcome results from the randomised phase III REACH study
Journal:European Journal of Cancer
Chau, IPeck-Radosavljevic, MBorg, CMalfertheiner, PSeitz, JFPark, JORyoo, BYYen, CJKudo, MPoon, RTPPastorelli, DBlanc, JFChung, HCBaron, ADOkusaka, TBowman, LCui, ZLGirvan, ACAbada, PBYang, LZhu, AX
2017
 
Statutory rights and de facto constitutional supremacy in Hong Kong?
Proceeding/Conference:International Journal of Constitutional Law
Yap, PJChung, HC
2019
Showing results 1 to 7 of 7